Population Pharmacokinetics Study of Morinidazole in Patients with Moderate Hepatic Impairment
Yue Kang, Fengyan Xu, Kun Wang, Jing Zhang, Xiaojie Wu, Jufang Wu, Guoying Cao, Jicheng Yu, Beining Guo, Yuancheng Chen, Yingyuan Zhang
This study builds a population pharmacokinetic model of morinidazole in patients with hepatic impairment and provides dosage adjustment strategies based on covariates like disease status and weight.
bioRxiv · May 2, 2018 · PreprintPharmacology & Toxicology